1. Home
  2. CAH vs TCOM Comparison

CAH vs TCOM Comparison

Compare CAH & TCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardinal Health Inc.

CAH

Cardinal Health Inc.

HOLD

Current Price

$227.94

Market Cap

52.0B

Sector

Health Care

ML Signal

HOLD

TCOM

Trip.com Group Limited

HOLD

Current Price

$51.96

Market Cap

34.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAH
TCOM
Founded
1979
1999
Country
United States
Singapore
Employees
N/A
41073
Industry
Other Pharmaceuticals
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.0B
34.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CAH
TCOM
Price
$227.94
$51.96
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
$230.45
$78.33
AVG Volume (30 Days)
1.5M
3.7M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
0.89%
0.58%
EPS Growth
86.96
N/A
EPS
1.88
N/A
Revenue
$222,578,000,000.00
N/A
Revenue This Year
$17.34
$15.22
Revenue Next Year
$8.95
$13.20
P/E Ratio
$122.23
$9.06
Revenue Growth
N/A
N/A
52 Week Low
$120.72
$50.70
52 Week High
$233.60
$79.00

Technical Indicators

Market Signals
Indicator
CAH
TCOM
Relative Strength Index (RSI) 59.61 31.62
Support Level $206.07 N/A
Resistance Level $230.20 $64.47
Average True Range (ATR) 5.11 1.47
MACD 0.07 0.05
Stochastic Oscillator 71.86 29.32

Price Performance

Historical Comparison
CAH
TCOM

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

Share on Social Networks: